The AFFF phase-out is gaining momentum across the United States, and industrial operators can't afford to ignore the shift. Here's what's driving the transition - and what it means for facilities still using Class B foams.
Delivering the Promise of Gene Therapy
Gene therapy has come a long way in the last ten years. In the next decade, achieving efficiencies in its delivery will unlock its full potential.
Is Your Product Ready for Re-Registration? Why Strategic Compliance Is Critical for EU Market Access
In the European Union's stringent regulatory landscape, proactive compliance isn't just a necessity – it's a powerful strategic advantage. For plant protection product (PPP) companies, the upcoming re-registration process mandated by EU Regulation (EC) No 1107/2009, under Article 43, represents a critical juncture.
From Hospital Tools to Home Essentials: Reimagining Medical Devices for the Hospital at Home
As the hospital-at-home (HaH) movement gains momentum, we’re witnessing a transformation in how and where care is delivered. Medical devices, once exclusive to hospitals are now being adapted for home use.
4 Key Qualities to Look for In A PFAS Laboratory Testing Partner
For meaningful and defensible PFAS testing, you need a laboratory service provider that does more than run tests—you need one that understands PFAS. Here’s what to look for when selecting a partner for PFAS laboratory analysis.
Exploring New Frontiers: Brain-Computer Interfaces and Neurotechnology at Battelle
Restoring movement for people who live with paralysis has been a research imperative at Battelle since the early 2000s. Today this goal is closer than ever.
Sign Up for Battelle Updates
Follow along with the latest news, announcement and updates from our Battelle community of solvers.